The week in industry: European Commission authorizes marketing of new treatment for HIV-1 infection
This week: Cancer Research UK (London, UK) enter collaboration to develop new cancer medicines for patients, Parkinson’s UK investing GBP£1 million to slow the loss of brain cells in Parkinson’s and sponsors of clinical trials called to release results in EU database.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>